Because Dihexa activates HGF/c-Met signaling , and this pathway is also involved in some types of tumor progression, caution is advised in: Patients with active cancers History of certain malignancies No human data confirms a cancer risk, but Dihexa is best avoided in patients with cancer unless under strict clinical supervision
For context, the peptide half-life chart data shows that Semaglutide at 0.252.4 mg weekly achieves comparable research endpoints to Sermorelin at 100500 mcg daily, a difference directly attributable to their 400-fold difference in half-life
Gut recovery as performance recovery
Concentration accuracy matters
Dose NAD+ precursors in the morning alongside 5-Amino-1MQ to align with circadian synthesis peaks
the honest 2025 news of ashwagandha-linked liver injury (NIH LiverTox, the ACG 2025 herbal-supplement systematic review, Lareb, TGA and MHRA Yellow Card)